• OPEN AN ACCOUNT
Indian Indices
Nifty
24,578.35 -346.35
(-1.39%)
Sensex
81,148.22 -1,281.68
( -1.55%)
Bank Nifty
54,940.85 -442.00
( -0.80%)
Nifty IT
37,354.60 -927.95
( -2.42%)
Global Indices
Nasdaq
42,424.12 1,153.74
(2.80%)
Dow Jones
5,865.06 184.15
(3.24%)
Hang Seng
38,283.51 639.25
(1.70%)
Nikkei 225
8,602.92 -2.06
(-0.02%)
Forex
USD-INR
85.41 0.03
(0.03%)
EUR-INR
96.03 -0.26
(-0.27%)
GBP-INR
113.57 0.08
(0.07%)
JPY-INR
0.59 0.00
(-0.40%)

EQUITY - MARKET SCREENER

Nath Bio-Genes (India) Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
537291
INE448G01010
341.3302463
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATHBIOGEN
7.6
316.04
EPS(TTM)
Face Value()
Div & Yield %
21.89
10
1.2
 

atul ltd
Nestle India consolidated net profit declines 6.50% in the March 2025 quarter
Apr 24,2025
Net profit of Nestle India declined 6.50% to Rs 873.46 crore in the quarter ended March 2025 as against Rs 934.17 crore during the previous quarter ended March 2024. Sales rose 3.68% to Rs 5447.64 crore in the quarter ended March 2025 as against Rs 5254.43 crore during the previous quarter ended March 2024.

For the full year,net profit declined 18.44% to Rs 3207.59 crore in the year ended March 2025 as against Rs 3932.84 crore during the previous year ended March 2024. Sales declined 17.29% to Rs 20077.50 crore in the year ended March 2025 as against Rs 24275.48 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales5447.645254.43 4 20077.5024275.48 -17
OPM %25.2725.69 -23.6623.97 -
PBDT1347.481350.60 0 4672.625822.28 -20
PBT1192.141240.50 -4 4132.705284.50 -22
NP873.46934.17 -6 3207.593932.84 -18